Nucleic acid molecules that inhibit the expression of TSLP
TW202633660APending Publication Date: 2026-08-16MOCHIDA PHARM CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114142169
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-09-29
- Filing Date
- 2025-10-30
- Publication Date
- 2026-08-16
Abstract
This invention relates to nucleic acid molecules that can inhibit the expression of thymic stromal lymphopoietin (TSLP) or genes encoding TSLP, their salts, solvates, pharmaceutical compositions characterized by containing these as active ingredients, and preventive and / or therapeutic agents for diseases presumed to be related to TSLP.
Need to check novelty before this filing date? Find Prior Art